NOVARTIS - FOLLOWING 2 RECENT PATIENT FATALITIES IN ZOLGENSMA GENE THERAPY CO WILL BE UPDATING LABELING TO SPECIFY FATAL ACUTE LIVER FAILURE REPORTED